Cyclerion Therapeutics Inc Ordinary Shares (CYCN) Stock Price, Quote, News & History

Key Statistics

Open

Volume / Avg.

0 / 6.76K

Day Range

- - -

52 Wk Range

7.19 - 59.36

Market Cap

$16.24M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

Recent Cyclerion Therapeutics Inc Ordinary Shares News

Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy

Major M&A deals this week include: Eli Lilly's $7.8 billion purchase of Centessa Pharmaceuticals; Meanwhile, IO Biotech goes bankrupt.

Caroline Ryan

Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors' Radars Today

GSAT, XOM, CYCN, LLY, INTC were among the stocks seen trending on Wednesday, April 1, 2026.

Shivdeep Dhaliwal

Crude Oil Down Over 1%; ISM Manufacturing PMI Rises In March

US stocks traded higher with S&P 500 up 1%, Dow up 0.89%, and NASDAQ up 1.56%. Industrials shares rose 2.1% while energy stocks fell 4%.

Avi Kapoor

Cyclerion Therapeutics Stock Soars 350% On Korsana Merger, $380 Million Financing

Cyclerion Therapeutics shares are trading sharply higher Wednesday morning after it announced a merger agreement with Korsana Biosciences.

Henry Khederian

Dow Jumps Over 200 Points; Nike Shares Tumble After Q3 Results

Dow up 0.53%, NASDAQ up 1.05%, S&P 500 up 0.62%. Nike shares down 14% despite beating Q3 estimates. Cyclerion, RenX, Mega Fortune up, Neo-Concept down 61%. Oil down 2.6%, gold up 2%. European and Asian markets all up.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Key Statistics

Open

Volume / Avg.

0 / 6.76K

Day Range

- - -

52 Wk Range

7.19 - 59.36

Market Cap

$16.24M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

CYCN

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

CYCN

FAQ

How do I buy Cyclerion Therapeutics Inc Ordinary Shares (CYCN) stock?

You can purchase shares of Cyclerion Therapeutics Inc Ordinary Shares (NASDAQ:CYCN) through any online brokerage.

View our list of the best stock brokerages

Who are Cyclerion Therapeutics Inc Ordinary Shares (CYCN) competitors?

There are no as such competitors for Cyclerion Therapeutics Inc Ordinary Shares.

What is the forecast, or price target, for Cyclerion Therapeutics Inc Ordinary Shares (CYCN) stock?

There is no analysis for Cyclerion Therapeutics Inc Ordinary Shares to provide a consensus price target.

What is the current price for Cyclerion Therapeutics Inc Ordinary Shares (CYCN)?

The stock price for Cyclerion Therapeutics Inc Ordinary Shares (NASDAQ: CYCN) is $3.47 last updated September 8, 2026 at 7:34 PM EDT.

Does Cyclerion Therapeutics Inc Ordinary Shares (CYCN) pay a dividend?

There are no upcoming dividends for Cyclerion Therapeutics Inc Ordinary Shares.

When is Cyclerion Therapeutics Inc Ordinary Shares (NASDAQ:CYCN) reporting earnings?

Cyclerion Therapeutics Inc Ordinary Shares does not have any upcoming earnings scheduled.

Is Cyclerion Therapeutics Inc Ordinary Shares (CYCN) going to split?

There is no upcoming split for Cyclerion Therapeutics Inc Ordinary Shares.